DCA is not patented

February 4, 2007

DCA is an odourless, colourless, inexpensive, relatively non-toxic, small molecule. And researchers at the University of Alberta believe it may soon be used as an effective treatment for many forms of cancer.

One molecule that restores the body’s own cell self-destruct mechanism, a mechanism which is normally disabled in cancer cells. The molecule has already destroyed human cancer cells in lines grown in laboratory cultures, and even in human tumors grown in rats.

If this harmless molecule proves to be The One Cure against cancer (and right now, it looks like it, as even brain cancer is hypothesised to be affected by it), this will be one of the biggest medical discoveries in human history.

One problem though:

However, as DCA is not patented, Michelakis is concerned that it may be difficult to find funding from private investors to test DCA in clinical trials. He is grateful for the support he has already received from publicly funded agencies, such as the Canadian Institutes for Health Research (CIHR), and he is hopeful such support will continue and allow him to conduct clinical trials of DCA on cancer patients.

Seriously. I’ll do anything to keep funding for this going.

Messages »

No messages yet

RSS feed for messages on this post.

Leave a message

Line and paragraph breaks automatic, e-mail address never displayed, HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong> .

Please use the blockquote tag to quote. Comments containing quotes in other ways will be deleted.


-